ArticleInflammatory bowel diseases2025

Clinical Utility and Accuracy of Point-of-Care Testing for Anti-TNF Drug Monitoring and Loss of Response.

Christoph Teichert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.